05/23/2016
https://www.congress.gov...
"As chairman of the Pricing, Reimbursement, and Access Steering Committee for Lilly USA and as the relevant profit and loss business unit leader for the biomedicines business unit for the United States..."
"No amount of flexibility is going to compensate for those types of cuts."
"To say this administration hasn't yet delivered would be a wild understatement."
"The same Donald Trump who said almost exactly one year ago that price-hiking drug companies were 'getting away with murder' has nominated a drug company executive."